维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Meeberg"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Total tumor volume and alpha‐fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation显示文摘	Christian Toso Glenda Meeberg Roberto Hernandez‐Alejandro Jean‐Fran?ois Dufour Paul Marotta Pietro Majno Norman M. Kneteman	2015	Hepatology2015，，1：	2
	2	Muhicentric out- come analysis of sirolimus-based immunosuppression in 252 liver transplant recipients显示文摘	Molinari M Berman K Meeberg G	2010	Transpl Int2010，23，2：	1
	3	Patients With Cirrhosis and Denied Liver Transplants Rarely Receive Adequate Palliative Care or Appropriate Management显示文摘	Zafrina Poonja Amanda Brisebois Sander Veldhuyzen van Zanten Puneeta Tandon Glenda Meeberg Constantine J. Karvellas	2014	Clinical Gastroenterology and Hepatology2014，，4：	1
	4	Multicentric outcome analysis of sirolimus-based mmunosuppression in252 liver transplant recipients显示文摘	Molinari M Berman K Meeberg G	2010	Transpl Int2010，23，2：	1
	5	Quality of life: a concept analysis 显示文摘	MEEBERG GA	1993	JAN1993，18，3：	1
	6	Ursodeoxyeholie acid therapy for primary selerosing cholangltis: results of a two - year randomized controlled trial to evaluate single versus multi- ple daily doses 显示文摘	Van Hoogstraten HJ Wolfhagen FH Vande Meeberg PC	1998	J Hepatol1998，29，3：	1
	7	Peri-operative medical e- mergency team activation in liver transplantation 显示文摘	Parmar A Meeberg G Bigam D	2011	BMJ Qual Saf2011，20，3：	1
	8	Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients显示文摘	Molinari M Berman K Meeberg G	2010	Transpl Int2010，23，2：	1
	9	Quality of life:a concept analysis显示文摘	MEEBERG G A	1993	JAN1993，18，3：	1
	10	Sirolimus‐based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma显示文摘	Norman M. Kneteman José Oberholzer Mohammed Al Saghier Glenda A. Meeberg Maurice Blitz Mang M. Ma Winnie W.S. Wong Klaus Gutfreund Andrew L. Mason Larry D. Jewell A.M. James Shapiro Vincent G. Bain David L. Bigam	2004	Liver Transpl2004，，10：	1
	11	De novo slrolimus-based inununosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects显示文摘	Toso C Meeberg CA Bigam DL	2007	Transplantation2007，83，9：	1
	12	Systematic review:the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease显示文摘	De Groot NL Burgerhart JS Van De Meeberg PC de Vries DR Smout AJ Siersema PD	2009	Aliment Pharmacol Ther2009，30，：	1
	13	Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients显示文摘	Molinari M Berman K Meeberg G		0，，02：	1
	14	Denovo sirolimusbased immunosuppression after liver transplantation for hepatocellular carcinoma:long-term outcomes and side effects显示文摘	Toso C Meeberg GA Bigam DL et a1	2007	Transplantation2007，83，9：	1
	15	De Novo Sirolimus-Based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects显示文摘	Christian Toso Glenda A. Meeberg David L. Bigam Jose Oberholzer A M. James Shapiro Klaus Gutfreund Mang M. Ma Andrew L. Mason Winnie W. S. Wong Vincent G. Bain Norman M. Kneteman	2007	Transplantation2007，，9：	1
	16	Factors predicting survival after post-transplant hepatocellular carcinoma recurrence显示文摘	Christian Toso Sonia Cader Ariane Mentha-Dugerdil Glenda Meeberg Pietro Majno Isabelle Morard Emiliano Giostra Thierry Berney Philippe Morel Gilles Mentha Norman M. Kneteman	2013	Journal of Hepato-Biliary-Pancreatic Sciences2013，，3：	1
	17	Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy显示文摘Hepatosplenic T-cell lymphoma(HSTCL) is a rare nonHodgkin lymphoma with a high mortality rate. Higher incidence is reported in patients with inflammatory bowel disease, specifically in male patients that are younger than 35 years, and have been treated with thiopurine and tumor necrosis factor(TNF)-α inhibitor combination therapy for over 2 years. In this case report we describe a 47-year-old patient with Crohn's disease(CD) who developed HSTCL after having been treated with thiopurine monotherapy for 14 years. To our best knowledge, only eleven cases exist of patients with CD who developed HSTCL while on thiopurine monotherapy. We report the first patient with CD, older than 35 years, who developed HSTCL while on thiopurine monotherapy. This emphasizes that HSTCL risk is not limited to young men receiving both thiopurines and TNF-α inhibitors.	Maartje M van de Meeberg Lauranne AAP Derikx Harm AM Sinnige Peet Nooijen D Lucette Schipper Loes HC Nissen	2016	World Journal of Gastroenterology2016，22，47：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费